Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

23andMe Data Breach Larger Than Previously Reported

Is the genetic testing company trying to avoid liability?

Executive Summary

The numbers for the genetic testing company’s October data breach are much larger than previously reported, and now the company might be trying to shield itself from class action lawsuits. 

You may also be interested in...



News We’re Watching: Synovo Hip Warning, 23andMe Lawsuit, Public Citizen Co-Founder Dies

This week, the FDA told providers not to use Synovo’s total hip resurfacing system because it’s been modified since it was cleared; 23andMe is facing another class action suit related to its October data breach; and North Carolina Rep. Gregory Murphy asked FDA Commissioner Robert Califf to avoid a one-size-fits-all approach in AI regulation.

Federal Government Takes Action To Protect American Data

The Biden administration issued an executive order to protect American data privacy. On the same day, the Senate HELP committee released its report on health data privacy with suggestions to update HIPAA for a modern healthcare world. 

UnitedHealth Group Cyber Attack Disrupts Major Pharmacies For A Week With No End In Sight

Systems from Change Healthcare are experiencing disruptions for the seventh day in a row after a ransomware attack on parent company UnitedHealth Group.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel